Iambic Therapeutics Inc. (IAM) Stock Ticker
IAM right now
Market factors today
Unlock the full IAM picture
About Iambic Therapeutics Inc.
Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded by Thomas Miller and Fred Manby on October 14, 2019 and is headquartered in San Diego, CA.
IAM stock facts
| Ticker symbol | IAM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $133.9M |
| CEO | Thomas Miller |
| Employees | 171 |
| Headquarters | San Diego, CA, US |
| IPO date | 2026-10-15 |
| Website | www.iambic.ai |
What you can see for IAM on Tickr
Live IAM price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the IAM report.
Rankings
FAQ
What is the ticker symbol for Iambic Therapeutics Inc.?
The ticker symbol for Iambic Therapeutics Inc. is IAM, listed on the NASDAQ.
What is IAM?
Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded by Thomas Miller and Fred Manby on October 14, 2019 and is headquartered in San Diego, CA.